Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
8.79
-0.04 (-0.45%)
At close: May 30, 2025, 4:00 PM
8.56
-0.23 (-2.62%)
After-hours: May 30, 2025, 7:50 PM EDT
Viatris Revenue
Viatris had revenue of $3.25B in the quarter ending March 31, 2025, a decrease of -11.17%. This brings the company's revenue in the last twelve months to $14.33B, down -6.71% year-over-year. In the year 2024, Viatris had annual revenue of $14.74B, down -4.46%.
Revenue (ttm)
$14.33B
Revenue Growth
-6.71%
P/S Ratio
0.73
Revenue / Employee
$447,819
Employees
32,000
Market Cap
10.32B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 14.74B | -687.60M | -4.46% |
Dec 31, 2023 | 15.43B | -835.80M | -5.14% |
Dec 31, 2022 | 16.26B | -1.62B | -9.08% |
Dec 31, 2021 | 17.89B | 5.94B | 49.73% |
Dec 31, 2020 | 11.95B | 445.50M | 3.87% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
VTRS News
- 23 hours ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - PRNewsWire
- 1 day ago - VTRS CLASS NOTICE: Viatris Inc. Investors may have been Affected by Fraud – Contact BFA Law before June 3 Court Deadline (NASDAQ:VTRS) - GlobeNewsWire
- 1 day ago - SHAREHOLDER REMINDER: Berger Montague Reminds Viatris (NASDAQ: VTRS) Investors of the June 3, 2025 Deadline - GlobeNewsWire
- 4 days ago - DEADLINE NEXT WEEK: Berger Montague Advises Viatris (NASDAQ: VTRS) Investors to Contact the Firm Before June 3, 2025 - GlobeNewsWire
- 7 days ago - VTRS FRAUD: Suffer Losses on Viatris Inc.? You may have been Affected by Fraud and are Urged to Contact BFA Law (NASDAQ:VTRS) - GlobeNewsWire
- 8 days ago - VTRS FRAUD NEWS: Viatris Inc. is Being Sued for Securities Fraud; Investors That Lost Money Are Urged to Contact BFA Law by June 3 Court Deadline - Accesswire
- 10 days ago - Viatris to Participate in Upcoming Investor Conferences - PRNewsWire
- 10 days ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Viatris Lawsuit – VTRS - GlobeNewsWire